Lavipharm (ATH:LAVI) Operating Cash Flow per Share : €0.01 (TTM As of Jun. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Operating Cash Flow per Share?

Lavipharm's operating cash flow per share for the six months ended in Jun. 2024 was €0.02. Lavipharm's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Lavipharm was -68.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -76.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -40.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Lavipharm's Operating Cash Flow per Share or its related term are showing as below:

ATH:LAVI' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -76.6 Med: 18.85 Max: 46.3
Current: -76.6

During the past 7 years, Lavipharm's highest 3-Year average Operating Cash Flow per Share Growth Rate was 46.30% per year. The lowest was -76.60% per year. And the median was 18.85% per year.

ATH:LAVI's 3-Year OCF Growth Rate is ranked worse than
97.82% of 780 companies
in the Drug Manufacturers industry
Industry Median: 8.85 vs ATH:LAVI: -76.60

Lavipharm Operating Cash Flow per Share Historical Data

The historical data trend for Lavipharm's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Operating Cash Flow per Share Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.16

0.24

0.16

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial						0.14	0.04	0.01	-0.01	0.02

Competitive Comparison of Lavipharm's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Lavipharm's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lavipharm's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lavipharm's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lavipharm's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Lavipharm Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Lavipharm's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	0.284	/	168.205
	=	0.00

Lavipharm's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )	=	Cash Flow from Operations (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	3.59	/	167.961
	=	0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01

Lavipharm Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Lavipharm's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

BXA0:Germany

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines